Verapamil hydrochloride and Thrombocytopenia - a phase IV clinical study of FDA data
We study 5,040 people who have side effects when taking Verapamil hydrochloride. Thrombocytopenia is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Furosemide and have Multiple myeloma.
The phase IV clinical study analyzes which people take Verapamil hydrochloride and have Thrombocytopenia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
5,040 people reported to have side effects when taking Verapamil hydrochloride.
Among them, 100 people (1.98%) have Thrombocytopenia.
What is Verapamil hydrochloride?
Verapamil hydrochloride has active ingredients of verapamil hydrochloride. It is used in high blood pressure. Currently, eHealthMe is studying from 6,223 Verapamil hydrochloride users.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 3,929 drugs and 4,724 conditions by eHealthMe. Currently, we are studying 269,174 people who have Thrombocytopenia.
Number of Verapamil hydrochloride and Thrombocytopenia reports submitted per year:
Time on Verapamil hydrochloride when people have Thrombocytopenia *:
- < 1 month: 77.78 %
- 1 - 6 months: 22.22 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Thrombocytopenia when taking Verapamil hydrochloride *:
- female: 51.58 %
- male: 48.42 %
Age of people who have Thrombocytopenia when taking Verapamil hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 5.26 %
- 40-49: 4.21 %
- 50-59: 15.79 %
- 60+: 74.74 %
Common drugs people take besides Verapamil hydrochloride *:
- Furosemide: 11 people, 11.00%
- Lasix: 9 people, 9.00%
- Digoxin: 8 people, 8.00%
- Aldactone: 8 people, 8.00%
- Aspirin: 8 people, 8.00%
- Isosorbide Dinitrate: 7 people, 7.00%
- Prednisolone: 7 people, 7.00%
- Samsca: 6 people, 6.00%
- Oxycontin: 6 people, 6.00%
- Acetaminophen: 6 people, 6.00%
Common side effects people have besides Thrombocytopenia *:
- Haemoglobin Decreased: 18 people, 18.00%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 17 people, 17.00%
- White Blood Cell Count Decreased: 17 people, 17.00%
- Fever: 13 people, 13.00%
- Nausea (feeling of having an urge to vomit): 12 people, 12.00%
- Anaemia (lack of blood): 12 people, 12.00%
- Hypotension (abnormally low blood pressure): 10 people, 10.00%
- Fatigue (feeling of tiredness): 9 people, 9.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 9.00%
- Renal Failure Acute (rapid kidney dysfunction): 7 people, 7.00%
Common conditions people have *:
- Multiple Myeloma (cancer of the plasma cells): 9 people, 9.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 5.00%
- Stable Angina (a constant chest pain): 5 people, 5.00%
- Herpes Zoster: 5 people, 5.00%
- Arrhythmias (irregular heartbeat): 4 people, 4.00%
- Osteoporosis (bones weak and more likely to break): 4 people, 4.00%
- Cardiac Failure Congestive: 4 people, 4.00%
- Cardiac Failure: 4 people, 4.00%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 3.00%
- Breast Cancer: 3 people, 3.00%
* Approximation only. Some reports may have incomplete information.
Do you take Verapamil hydrochloride and have Thrombocytopenia?Check whether Thrombocytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Verapamil hydrochloride side effects by duration, gender and age:
- Verapamil hydrochloride side effects (6,223 reports)
Thrombocytopenia treatments and more:
- Thrombocytopenia (269,174 reports)
Common drugs associated with Thrombocytopenia:
- Revlimid: 14,996 reports
- Prednisone: 12,592 reports
- Aspirin: 11,527 reports
- Dexamethasone: 10,093 reports
- Cyclophosphamide: 9,104 reports
- Carboplatin: 9,097 reports
- Methotrexate: 9,000 reports
- Omeprazole: 8,168 reports
- Allopurinol: 8,019 reports
- Lopurin: 8,013 reports
All the drugs that are associated with Thrombocytopenia:
- Thrombocytopenia (3,929 drugs)
Common conditions associated with Thrombocytopenia:
- Multiple myeloma: 21,573 reports
- High blood pressure: 10,211 reports
- Ovarian cancer: 7,159 reports
- Pain: 5,887 reports
- Hepatitis c: 5,635 reports
- Rheumatoid arthritis: 5,401 reports
All the conditions that are associated with Thrombocytopenia:
- Thrombocytopenia (4,724 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on verapamil hydrochloride (the active ingredients of Verapamil hydrochloride) and Verapamil hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Abacavir Sulfate and Movement - Uncoordinated - 7 seconds ago
- Zopiclone and Kevzara drug interaction - 8 seconds ago
- Reclast and Celexa drug interaction - 8 seconds ago
- Lotrel and Uloric drug interaction - 8 seconds ago
- Seroquel and Feelings Of Worthlessness - 18 seconds ago
- Glipizide and Loniten drug interaction - 25 seconds ago
- Nexavar and Riboflavin drug interaction - 27 seconds ago
- Sodium Chloride 0.9% and Dupixent drug interaction - 31 seconds ago
- Fluvastatin and Symbicort drug interaction - 35 seconds ago
- Coq and Dementia - 38 seconds ago